In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.
In the latest session, Rhythm Pharmaceuticals Inc (NASDAQ: RYTM) closed at $63.02 down -2.81% from its previous closing price of $64.84. In other words, the price has decreased by -$2.81 from its previous closing price. On the day, 0.78 million shares were traded.
Ratios:
For a deeper understanding of Rhythm Pharmaceuticals Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.13 and its Current Ratio is at 3.30. In the meantime, Its Debt-to-Equity ratio is 13.60 whereas as Long-Term Debt/Eq ratio is at 13.50.
On January 02, 2025, Jefferies started tracking the stock assigning a Buy rating and target price of $80.Jefferies initiated its Buy rating on January 02, 2025, with a $80 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Jun 10 ’25 when German Christopher Paul sold 2,069 shares for $67.19 per share. The transaction valued at 139,016 led to the insider holds 1,889 shares of the business.
Cramer Pamela J. sold 7,031 shares of RYTM for $478,435 on Jun 06 ’25. The Chief Human Resources Officer now owns 19,209 shares after completing the transaction at $68.05 per share. On Jun 10 ’25, another insider, CHRISTOPHER PAUL GERMAN, who serves as the Officer of the company, bought 2,069 shares for $66.72 each.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 29.30 while its Price-to-Book (P/B) ratio in mrq is 211.19.
Stock Price History:
Over the past 52 weeks, RYTM has reached a high of $69.89, while it has fallen to a 52-week low of $39.46. The 50-Day Moving Average of the stock is 2.97%, while the 200-Day Moving Average is calculated to be 12.31%.
Shares Statistics:
A total of 63.49M shares are outstanding, with a floating share count of 58.22M. Insiders hold about 8.48% of the company’s shares, while institutions hold 95.60% stake in the company.
